Showing 321-325 of 325 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Colonic Delivery of Butyrate to Improve Insulin Sensitivity and Lower Triglycerides in Type 1 Diabetes Patients | Mayo Clinic | Adrian Vella | Improving Lives | 01-October-2019 to 31-March-2025 | $365.991,93 |
| Evaluation of the safety, tolerability, and general response to Lactobacillus johnsonii N6.2 in children and adolescents with T1D | University of Florida | Graciela Lorca | Cures | 01-September-2019 to 31-August-2026 | $355.941,78 |
| Early immune and beta cell monitoring predicts treatment response | Benaroya Research Institute at Virginia Mason | S. Alice Long | Cures | 01-August-2019 to 31-July-2025 | $2.499.814,79 |
| Can Addition of Pioglitazone to SGLT2 Inhibitor in Type 1 Diabetic Patients Amplify the Decrease in HbA1c and Mitigate Diabetic Ketoacidosis Risk? | University of Texas Health Science Center at San Antonio | Muhammad Abdul-Ghani | Improving Lives | 01-June-2019 to 31-December-2026 | $1.573.835,31 |
| Triple therapy for T1DM with insulin, semaglutide and dapagliflozin | The Research Foundation of SUNY on behalf of University at Buffalo | Paresh Dandona | Improving Lives | 01-January-2019 to 31-March-2026 | $1.808.522,70 |